Recombinant Mycoplasma pneumoniae Uncharacterized protein MPN_614 (MPN_614)
Product Specs
Q&A
Basic Research Questions
What genomic and structural features define MPN_614 in M. pneumoniae?
MPN_614 (gene locus MPN614) is a 334-amino-acid conserved hypothetical protein encoded by nucleotides 737,155–738,159 in the M. pneumoniae genome. It lacks functional annotation but shares conserved domains with uncharacterized proteins across mycoplasma species . Key features:
-
Molecular weight: ~37 kDa (predicted)
-
Subcellular localization: Unknown (no transmembrane domains predicted)
-
Conservation: Found in M. pneumoniae strains but absent in other human-pathogenic mycoplasmas .
Why is MPN_614 considered "uncharacterized," and how can researchers prioritize its study?
MPN_614 lacks experimental validation of its role in virulence, metabolism, or host interaction. Prioritization strategies include:
-
Phylogenetic profiling: Compare its presence/absence across mycoplasma species with varying pathogenicity .
-
Co-expression analysis: Identify genes consistently transcribed with MPN_614 using RNA-seq datasets .
-
Domain prediction: Use tools like InterProScan to detect potential functional motifs (e.g., enzymatic or binding domains).
Advanced Research Questions
What expression systems are optimal for producing recombinant MPN_614?
-
E. coli systems: Use GST- or His-tagged constructs in BL21(DE3) strains, as demonstrated for other M. pneumoniae proteins .
-
Solubility optimization: Test induction temperatures (16–25°C) and additives (0.5 M arginine/glutamate) to address aggregation .
-
Validation: Confirm identity via Western blot (anti-tag antibodies) and MALDI-TOF mass spectrometry.
How can protein-protein interaction studies elucidate MPN_614's function?
What role might MPN_614 play in M. pneumoniae pathogenesis?
Hypotheses and testing approaches:
-
Immune modulation: Measure cytokine responses (TNF-α, IL-6) in macrophages exposed to recombinant MPN_614 .
-
Adhesion/gliding: Compare ΔMPN_614 mutants with wild-type motility using time-lapse microscopy .
-
Metabolic function: Perform metabolomic profiling of MPN_614-knockout strains .
How to resolve contradictions in MPN_614 functional data?
-
Knockout validation: Generate multiple independent ΔMPN_614 mutants to rule out off-target effects .
-
Complementation assays: Restore wild-type MPN_614 via plasmid-based expression and compare phenotypes .
-
Multi-omics integration: Cross-reference transcriptomic, proteomic, and metabolomic datasets .
What structural biology techniques are suitable for MPN_614 characterization?
| Technique | Application | Required Sample Prep |
|---|---|---|
| X-ray crystallography | Resolve 3D structure at <3 Å | High-purity (>95%) protein, crystallization screening |
| Cryo-EM | Study conformational changes in solution | Low-concentration samples (0.5–1 mg/mL) |
| NMR | Map dynamic regions (e.g., disordered domains) | Isotope-labeled protein (15N/13C) |
Methodological Considerations
-
Antibody development: Immunize rabbits with recombinant MPN_614 (100 µg/dose, Freund’s adjuvant) for Western blot/IF validation .
-
Phenotypic assays: Use M. pneumoniae cytadherence mutants (e.g., III-4 ) as controls in adhesion studies.
-
Data reproducibility: Include triplicate biological replicates and statistical validation (e.g., ANOVA with Tukey’s post-hoc test) .
